Visual Cortical Prosthesis

About NeuralInk

Neuralink, founded in 2016, is a private medical device company at the forefront of brain-computer interface technology. Its core innovation is the N1 implant and the surgical robot used for precise implantation of ultra-thin electrode threads. The company's initial focus is on therapeutic applications for paralysis and blindness, with a first-in-human clinical trial underway. Backed by significant private investment and led by Elon Musk, Neuralink aims to translate its ambitious platform from medical restoration to broader human augmentation.

Therapeutic Areas